Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, has appointed Dr Ramesh Kinha as its Chief Operating Officer, further strengthening its leadership team as the company continues to scale its operations across India.
Dr Kinha is a seasoned healthcare and diagnostics leader with over 17 years of experience across leading organisations in the diagnostics sector, with deep expertise in laboratory operations and quality systems. In his new role, he will be responsible for overseeing lab operations and strengthening quality standards across Thyrocare’s network, with a clear focus on consistently raising the bar on diagnostic accuracy and service delivery.
Prior to joining Thyrocare, Dr Kinha served as Group Director – Laboratory Services at Vijaya Diagnostic Centre Limited, where he led critical operational and quality initiatives. His extensive career includes senior leadership roles at Apollo Health & Lifestyle Ltd, Medall Healthcare, Metropolis Healthcare, and SRL Ltd, where he has delivered operational excellence and driven strategic transformation.
Commenting on his appointment, Dr Ramesh Kinha, Chief Operating Officer of Thyrocare, stated, “Thyrocare has always been a pioneer in making healthcare accessible while striving for excellence. I am excited to lead the charge in optimising our operations, strengthening our quality frameworks, and driving initiatives that will enable us to reach every Indian with affordable, world-class diagnostic services.”
A medical professional with strong academic credentials, Dr Kinha holds an MBBS degree and an MD in Pathology. He has also completed senior management and leadership programmes at IIM Nagpur and ISB (Indian School of Business). As a certified NABL (National Accreditation Board for Testing and Calibration Laboratories) assessor, he brings strong expertise in quality and regulatory excellence.
Rahul Guha, Managing Director and CEO of API Holdings, said, “As Thyrocare continues to scale, strengthening our leadership team is critical. Dr Kinha brings deep operational and quality expertise, along with experience in building high-performance laboratory networks. We are confident that his leadership will strengthen our operational backbone and support our vision of making quality diagnostics accessible to every Indian.”
As part of API Holdings, Thyrocare remains dedicated to its mission of democratising healthcare access through affordable, accurate, and timely diagnostic services. Dr Kinha’s appointment underscores the company’s commitment to investing in strong leadership and operational capabilities to support sustainable growth.
About Thyrocare
Thyrocare Technologies Limited (NSE: THYROCARE, BSE: 539871) is India’s first and foremost advanced fully automated laboratory chain with a strong presence PAN India. Thyrocare focuses on providing quality and affordable diagnostic services to laboratories and hospitals. Many laboratories and hospital brands all over India use the comprehensive test profile menu offered by Thyrocare.
Thyrocare has an extensive network of laboratories across PAN India. Thyrocare has a quarterly active franchise count of 10,000+ and processed 53.3 mn+ diagnostic and screening investigations in Q2FY26.
Thyrocare is one of the first Indian diagnostic laboratories to obtain internationally renowned quality accreditations, including ISO 9001-2000 rating as early as 2001, which was upgraded to ISO 9001:2015 and National Accreditation Board for Testing and Calibration Laboratories (NABL) and College of American Pathologists (CAP) accreditations in 2005.
FOR MORE BLOGS – beyondthepunchlines.com
Author: Team BTP
Add to favorites
